QP-Brain

Quibim
QP-Brain is a medical image processing application intended for automatic labeling and volumetric quantification of segmentable brain structures and White matter hyperintensities (WMH) from a set of MR images. Volumetric measurements may be compared to reference percentile data. The application is used by trained medical professionals, such as radiologists and neuroradiologists, as well as by clinical researchers, as a support tool in the assessment of structural MRIs.
Information source: Vendor
Last updated: January 30, 2024

General Information

General
Product name QP-Brain
Company Quibim
Subspeciality Neuro
Modality MR
Disease targeted Alzheimer’s Disease, Frontotemporal dementia, Mild Cognitive Impariment (MCI), Multiple Sclerosis
Key-features Brain segmentation, volume calculation, white matter hyperintensities quantification
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps)

Technical Specifications

Data characteristics
Population Patients with suspected or confirmed conditions associated with brain atrophy/white matter hyperintensities such as neurodegenerative diseases.
Input 3D T1w gradient echo, T2 FLAIR
Input format DICOM
Output Segmentation and quantification of grey matter, white matter, and CSF and their parcellation in several anatomical subregions. Segmentation and quantification of white matter hyperintensities.
Output format DICOM PDF
Technology
Integration Integration in standard reading environment (PACS)
Deployment Cloud-based
Trigger for analysis Automatically, right after the image acquisition
Processing time

Regulatory

Certification
CE
Certified, Class IIa , MDR
FDA 510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE) QP-Brain® is a medical image processing application intended for automatic labeling and volumetric quantification of segmentable brain structures and white matter hyperintensities (WMH) from a set of MR images.

Market

Market presence
On market since 12-2023
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Subscription
Based on Number of analyses

Evidence

Evidence
Peer reviewed papers on performance

  • Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study (read)

Non-peer reviewed papers on performance
Other relevant papers

  • Artificial intelligence and radiation effects on brain tissue in glioblastoma patient: preliminary data using a quantitative tool (read)